Nobelpharma clinical trials
Part of Hisanaga & Co., Ltd., which holds 73.9% as of 2025-12-31. Source
The registry lists 34 studies whose lead sponsor is Nobelpharma. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 17, 2025.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 34studies on the registry
- 0open to participants now
What it is testing
The drugs Nobelpharma’s studies test, most studies first; none is open now — 14 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- NPC-014 in phase 30 open · 4
- Topical Sirolimus3 in phase 30 open · 4
- Zinc Acetate4 in phase 30 open · 4
- NPC-061 in phase 30 open · 3
- Ethinyl Estradiol2 in phase 30 open · 2
- Melatonin2 in phase 30 open · 2
- Norethindrone2 in phase 30 open · 2
- 0 open · 2
- Aminolevulinic Acid1 in phase 30 open · 1
- Caffeine1 in phase 30 open · 1
Show 4 moreShow fewer
- caffeine citrate1 in phase 30 open · 1
- fosphenytoin1 in phase 30 open · 1
- Oxcarbazepine1 in phase 30 open · 1
- sargramostim1 in phase 30 open · 1
All 34 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 515
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 4 started before 2008. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Nobelpharma.
- Nobelpharma34 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 34 of 34.
- Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female VolunteersCompletedNCT01246791Phase 3
- A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus InfectionCompletedNCT04225923Phase 2
- Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With EndometriosisCompletedNCT00902746Phase 3
- Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary DysmenorrheaCompletedNCT00746096Phase 3
- Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female VolunteersCompletedNCT01253824Phase 3
- Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.CompletedNCT00212355Phase 3
- Efficacy and Safety Study of NPC-01 to Treat DysmenorrheaCompletedNCT01129102Phase 3
- Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSCCompletedNCT05495425Phase 3
- A Phase II/III Study of SargramostimCompletedNCT04642950Phase 2/3
- NPC-06 to Pain Associated With Acute Herpes ZosterCompletedNCT05480553Phase 3
- A Long-term Study of NPC-12G Gel in Neurofibromatosis Type ITerminatedNCT04461886Phase 3
- Efficacy Confirmation Study of NPC-09CompletedNCT04671472Phase 3
- An Additional Study of NPC-22 in Healthy Adult MalesCompletedNCT04503863Phase 1
- NPC-06 to Acute Pain in Herpes ZosterTerminatedNCT04139330Phase 2
- Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in CancerTerminatedNCT03773055Phase 2
- A Study of NPC-22 in Healthy Adult MalesCompletedNCT04203862Phase 1
- NPC-12G Gel 0.2% Sirolimus PK Bridging StudyCompletedNCT03972462Phase 1
- Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedNCT01051193Phase 2/3
- A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc DeficiencyCompletedNCT02337569Phase 3
- Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum DisordersCompletedNCT02757066Phase 2/3
- Dose Adjustment Study of NPC-02 in Patients With Zinc DeficiencyCompletedNCT02321865Phase 3
- Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental DisordersCompletedNCT02757079Phase 3
- Efficacy and Safety, Long-Term Study of NPC-16 to Treat DysmenorrheaCompletedNCT02362711Phase 3
- Bioequivalence Study of NPC-12 (Sirolimus) Granules and TabletsCompletedNCT03765944Phase 1
- Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexCompletedNCT02634931Phase 3
- Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)CompletedNCT03475459Phase 1
- Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)CompletedNCT02635789Phase 3
- Clinical Study of Caffeine for Apnea of PrematurityCompletedNCT01408173Phase 3
- Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma MultiformeCompletedNCT00919737Phase 1/2
- Study of NPC-07 for Fluorescence-guided Resection of Malignant GliomasCompletedNCT01167322Phase 3
- Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.CompletedNCT00212368Phase 3
- Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.CompletedNCT00212277Phase 3
- Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat DysmenorrheaCompletedNCT00212342Phase 3
- The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of FosphenytoinCompletedNCT00908453Phase 3